Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | JNCE | DERM | RLMD | ||
Company | Jounce Therapeutics Inc | Journey Medical Corp | Relmada Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.9200 | 5.18 | 3.04 | ||
High | 1.9300 | 5.33 | 3.06 | ||
Low | 1.8800 | 5.11 | 2.99 | ||
Last | 1.8800 | 5.21 | 3.02 | ||
Change | -0.0500 | +0.06 | +0.01 | ||
% Change | -2.59% | +1.17% | +0.33% | ||
Volume | 11,600,600 | 37,200 | 97,900 | ||
20-Day Average Volume | 1,541,820 | 113,800 | 63,000 | ||
Previous Close | 1.9300 | 5.15 | 3.01 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.9078 | 5.30 | 3.02 | ||
20-Day Raw Stochastic | 16.67% | 46.21% | 35.29% | ||
20-Day Relative Strength | 62.73% | 57.09% | 40.73% | ||
Weighted Alpha | -65.90 | +100.65 | -16.54 | ||
Today's Opinion | 24% Buy | 56% Buy | 80% Sell | ||
Previous Opinion | 40% Buy | 56% Buy | 80% Sell | ||
Last Month's Opinion | 24% Buy | 8% Sell | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.59% since 04/26/23 | +1.36% since 06/27/24 | +1.00% since 06/27/24 | ||
Low | 1.8800 on 05/03/23 | 5.07 on 06/28/24 | 2.96 on 06/28/24 | ||
High | 1.9500 on 04/28/23 | 5.65 on 06/28/24 | 3.08 on 07/01/24 | ||
1-Month | |||||
%Chg | +1.62% since 04/03/23 | +17.08% since 06/05/24 | +2.03% since 06/05/24 | ||
Low | 1.8400 on 04/04/23 | 4.40 on 06/06/24 | 2.90 on 06/07/24 | ||
High | 1.9800 on 04/17/23 | 6.15 on 06/12/24 | 3.24 on 06/10/24 | ||
3-Month | |||||
%Chg | +55.37% since 02/03/23 | +41.58% since 04/05/24 | -34.20% since 04/05/24 | ||
Low | 0.8957 on 03/10/23 | 3.20 on 05/21/24 | 2.45 on 06/05/24 | ||
High | 1.9800 on 04/17/23 | 6.15 on 06/12/24 | 5.09 on 04/09/24 | ||
6-Month | |||||
%Chg | -10.48% since 11/03/22 | +3.17% since 01/05/24 | -9.04% since 01/05/24 | ||
Low | 0.5773 on 12/13/22 | 2.85 on 03/25/24 | 2.45 on 06/05/24 | ||
High | 2.1180 on 11/09/22 | 6.15 on 06/12/24 | 7.22 on 03/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 98,954 | 103,067 | 90,824 | ||
Shares Outstanding, K | 52,635 | 20,013 | 30,174 | ||
Annual Sales | 82,000,000 | 79,180,000 | 0 | ||
Annual Net Income | -50,920,000 | -3,850,000 | -98,790,000 | ||
Last Quarter Sales | 82,000,000 | 13,030,000 | 0 | ||
Last Quarter Net Income | 50,960,000 | -10,440,000 | -21,830,000 | ||
60-Month Beta | 0.75 | 0.93 | 0.50 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.60 on 11/10/22 | -0.53 on 05/13/24 | -0.72 on 05/08/24 | ||
Latest Earnings Date | 05/04/23 | 08/13/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |